Clinical Trials Logo

Metabolism clinical trials

View clinical trials related to Metabolism.

Filter by:

NCT ID: NCT04500769 Completed - Metabolism Clinical Trials

Training Induced Muscle Exosome Release

TIMER
Start date: March 14, 2019
Phase: N/A
Study type: Interventional

The primary objective of this study is to quantify miR-1 release from muscle in extra-cellular vesicles following an acute resistance exercise bout and potential delivery to subcutaneous adipose tissue in young healthy and obese adults.

NCT ID: NCT04356573 Completed - Metabolism Clinical Trials

(KIWI) Speeding up a Slow Protein for Muscle Mass With Hay Kiwifruit

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The specific hypothesis is that the consumption of 2 Hayward green kiwifruit (containing actinidin protease) prior to 100g of ground beef will increase the rate of protein digestion from the beef in the elderly, leading to an increased uptake of the essential amino acids. Furthermore, this increased essential amino acid availability will produce a greater postprandial net anabolic protein response, as well as increased fractional synthetic rates of muscle proteins.

NCT ID: NCT04255368 Completed - Metabolism Clinical Trials

Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response

Start date: November 9, 2017
Phase: N/A
Study type: Interventional

The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.

NCT ID: NCT04180787 Completed - Metabolism Clinical Trials

Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance

Start date: December 5, 2019
Phase: N/A
Study type: Interventional

The purpose of this randomized, double-blind, crossover study is to investigate the effects of Bang® Keto Coffee on resting and post-exercise metabolism and muscular performance during lower body resistance exercise.

NCT ID: NCT04178694 Completed - Metabolism Clinical Trials

The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers

Ganesh
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Before inclusion in the trial. Careful medical history and medication use will be asked. Once included, 5 healthy subjects non-invasive ventilation(V60, Philips, Eindhoven, The Netherlands) will be administered at a level of positive end expiratory pressure (PEEP) of 4 cmH2O and without additional inspiratory support. Inspiratory support will then increase by 2 cmH2O every 2 minutes until 8 cmH2O is achieved for 2 minutes. The energy expenditure is measured using indirect calorimetry (Q-NRG®, Cosmed, Italy). To measure respiratory effort, the reversed RPE-scale was created for the purpose of the study. It uses the validated "rate of perceived exertion" scale (RPE-scale) which was altered by adding a reversed part. This could result in a score of -10 (no respiratory effort) until +10 ( maximal respiratory effort) where 0 represents the basal respiratory condition. Monitoring of heart rate, blood pressure and cardiac output will be done ( Nexfin®, BMEYE, Amsterdam, The Netherlands). After termination of the study clinical observation by principal investigator or co-investigator will be done for 15 minutes or until all side effects have worn off. If no side effects are observed, subjects will be released.

NCT ID: NCT04144426 Completed - Metabolism Clinical Trials

Meal Schedule Effects on Circadian Energy Balance in Adults

Start date: October 8, 2015
Phase: N/A
Study type: Interventional

This study will test will how eating on a particular daily schedule may effect energy, weight gain or loss, and body temperature.

NCT ID: NCT04078646 Completed - Metabolism Clinical Trials

Influence of Proteins on the Bioavailability of Carotenoids

CAROPROT
Start date: October 11, 2019
Phase: N/A
Study type: Interventional

A postprandial intervention study is conducted on healthy male subjects to evaluate whether the addition of proteins (why protein isolate, soy protein) can help to increase the bioavailability of carotenoids from a tomato/carrot beverage.

NCT ID: NCT04025346 Completed - Metabolism Clinical Trials

To Evaluate the Efficacy of Capsimax on Metabolic Rate

Start date: October 17, 2019
Phase: N/A
Study type: Interventional

Capsimax™ is a proprietary Capsicum Extract that employs Beadlet Technology. In the previous study it has been used to investigate its effect in reducing body fat/weight and increase metabolic rate. In this study, Capsimax™ will be used to assess effect on Resting Energy Expenditure (REE) using Indirect Calorimetry.

NCT ID: NCT04013607 Completed - Metabolism Clinical Trials

Fiber Fermentation Kinetics Inside the Gut, and Utilization of Bacterial Metabolites

Start date: July 8, 2019
Phase: N/A
Study type: Interventional

In this study, the life course of SCFA and their regulatory role in human metabolism will be traced using a nose-intestine catheter. The investigators have methodological questions: investigate the envisioned kinetic profiles of stable isotope tracers of SCFAs, and to establish the time points of plasma sampling (to determine systemic availability of SCFAs). The resulting timepoints established in this pilot study will be applied during a future human intervention study.

NCT ID: NCT03983733 Completed - Healthy Clinical Trials

PREDICT 2: Personalized Responses to Dietary Composition Trial 2

Start date: June 10, 2019
Phase: N/A
Study type: Interventional

Foods in the human diet can affect the development of diseases over time, such as diabetes or heart disease. This is because the amount and types of foods in the diet eat can affect a person's weight, and because different foods are metabolised (processed) by the body in different ways. Scientists have also found that the bacteria in the human gut (the gut microbiome) affect their metabolism, weight and health and that, together with a person's diet and metabolism, could be used to predict appetite and how meals affect the levels of sugar (glucose) and fats (lipids) found in blood after eating. If blood sugar and fat are too high too often for too long, there is a greater chance of developing diseases such as diabetes and cardiovascular disease. The gut microbiome is different in different people. Only 10-20% of the types of bacteria found in the human gut are found in everyone. This might mean that the best diet to prevent disease needs matching to a person's gut microbiome and it might be possible to find personalised foods or diets that will help reduce the chance of developing chronic disease as well as metabolic syndrome. The study investigators are recruiting volunteers aged 18-70 years to take part in a study that aims to answer the questions above. Participants will be asked to consume standardised meals on up to 8 days while wearing glucose monitors (Abbott Freestyle Libre) to measure their blood sugar levels. Participants will also be required to prick their fingers at regular intervals to collect small amounts of blood, and to record their appetite, food, physical activity and sleep using apps and wearable devices. They will be asked to collect a fecal and saliva sample before consuming the standardised meals, and to provide a fasted blood sample at the end of the study period.